20014 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the drug release technique; Application systems commanded by energy Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
Pharmaceutical formulations
#902Controlled release dosage form including a banded engine
#903Abuse-proofed dosage form
#904Capillary moderator for osmotic delivery system
#905Novel drug compositions and dosage forms of topiramate
#906Drug granule coatings that impart smear resistance during mechanical compression
#907Novel drug compositions and dosage forms
#908Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
#909Compositions and dosage forms for enhanced absorption
#910Stable pharmaceutical compositions containing pravastatin
#911Osmotic device containing a venlafaxine salt and a salt having an ion in common
#912Administration of levodopa and carbidopa
#913Compositions and dosage forms for enhanced absorption of iron
#914Compositions and dosage forms for enhanced absorption of gabapentin and pregabalin
#915Compositions and dosage forms for enhanced absorption of 3-amino-n-butyl-phosphinic acid
#916Rosiglitazone formulations
#917Controlled release formulations of opioid and nonopioid analgesics
#918Compositions and dosage forms for enhanced absorption of metformin
#919Controlled delivery of active agents
#920Stepwise delivery of topiramate over prolonged period of time
#921Osmotic delivery system flow modulator apparatus and method
#922Controlled release of topiramate in liquid dosage forms
#923Osmotic device containing licofelone
#924Devices and methods for pain management
#925Device for release of chemical molecules using pressure-generated rupture of reservoirs
#926Dihydroxy open-acid salt of simvastatin
#927Drug coating providing high drug loading
#928Dosage form for controlled release of an active agent formulation
#929Composition and dosage form comprising an interferon particle formulation and suspending vehicle
#930Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
#931Osmotically driven active agent delivery device providing an ascending release profile
#932Once-a-day, oral, controlled-release, oxycodone dosage forms
#933Melt blend dispersions
#934Drug-enhanced adhesion prevention
#935Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
#936Modular imbibition rate reducer for use with implantable osmotic pump
#937Device and method for accurate delivery of an active agent
#938Sustained release pharmaceutical composition
#939Osmotic pump with self-retaining, fast-start membrane plug
#940Treatment of gastroparesis and nonulcer dyspepsia with GABAB agonists
#941Oros push-stick for controlled delivery of active agents
#942Pharmaceutical formulation containing dye
#943Osmotic delivery system having space efficient piston
#944Osmotic engine & dosage form for controlled release of a liquid active agent formulation
#945Osmotic pump with means for dissipating internal pressure
#946Devices and methods for controlled delivery from a drug delivery device
#947Crystalline forms of conazoles and methods of making and using the same
#948System and method for correction of intracerebral chemical imbalances
#949Novel drug compositions and dosage forms of topiramate
#950Methods of treatment using a gastric retained gabapentin dosage
#951Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
#952Active drug delivery in the gastrointestinal tract
#953Osmotic delivery of therapeutic compounds by solubility enhancement
#954Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
#955Dosage form comprising self-destructive membrane
#956Controlled release composition with semi-permeable membrane and poloxamer flux enhancer
#957Osmotic delivery system with membrane plug retention mechanism
#958Osmotically-driven fluid dispenser
#959Dosage forms of cholesteryl ester transfer protein inhibitors and HMG-CoA reductase inhibitors
#960Spray drying processes for forming solid amorphous dispersions of drugs and polymers
#961Methods and devices for providing prolonged drug therapy
#962Methods and devices for providing prolonged drug therapy
#963Composite dosage forms
#964Controlled release solid dispersions
#965Osmotic delivery system and method for decreasing start-up times for osmotic delivery systems
#966Rupturing controlled release device having a preformed passageway
#967Non-aqueous single phase vehicles and formulations utilizing such vehicles
#968Orifice device having multiple channels with varying flow rates for drug delivery
#969Pharmaceutical coating composition and method of use
#970Implantable device having piston displacement monitoring
#971Pharmaceutical composition for modified release
#972Synergistic therapies for intervertebral disc degeneration
#973Methods of otoprotection against platinum-based antineoplastic agents
#974Compositions and methods for the treatment of trail-resistant cancer
#975Composition and method for treating neurological disease
#976Composition and method for treating neurological disease
#977Dose-dumping resistant controlled release dosage form
#978Dose-dumping resistant controlled release dosage form
#979Dose-dumping resistant controlled release dosage form
#980Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
#981Injectable sustained release delivery devices